Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Shimozuma · SciRah

Researcher profile · Semantic Scholar

K. Shimozuma

Share profile

K. Shimozuma — researcher profile on SciRah

h-index: 33
Works: 226
Citations: 4,287

Most-cited papers

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
T. Shiroiwa, T. Fukuda, S. Ikeda, A. Igarashi +3 more
2015Quality of Life Research303 citations Open access
Semantic Scholar
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
T. Shiroiwa, S. Ikeda, S. Noto, A. Igarashi +3 more
2016Value in Health297 citations Open access
Semantic Scholar
Developing a Japanese version of the EQ-5D-5L value set
S. Ikeda, T. Shiroiwa, A. Igarashi, S. Noto +3 more
2015229 citations
Semantic Scholar
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
T. Takashima, H. Mukai, F. Hara, N. Matsubara +12 more
2016The Lancet Oncology95 citations
Semantic Scholar
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
Y. Hagiwara, T. Shiroiwa, N. Taira, Takuya Kawahara +4 more
2020Health and Quality of Life Outcomes48 citations Open access
Semantic Scholar
A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients
Takanori Watanabe, H. Yagata, M. Saito, H. Okada +12 more
2019PLoS ONE40 citations Open access
Semantic Scholar
Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02
S. Ohsumi, K. Shimozuma, Y. Ohashi, A. Takeuchi +4 more
2012Oncology39 citations
Semantic Scholar
Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery
M. Saiga, N. Taira, Y. Kimata, S. Watanabe +9 more
2017Breast Cancer38 citations Open access
Semantic Scholar
Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity
T. Shiroiwa, T. Fukuda, K. Shimozuma
2019Quality of Life Research37 citations Open access
Semantic Scholar
Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial
T. Shiroiwa, T. Fukuda, K. Shimozuma, M. Mouri +7 more
2016Quality of Life Research32 citations Open access
Semantic Scholar
Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life 2 years after breast cancer surgery
N. Taira, K. Shimozuma, S. Ohsumi, K. Kuroi +3 more
2014Breast Cancer28 citations
Semantic Scholar
Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study
Y. Hagiwara, T. Shiroiwa, K. Shimozuma, Takuya Kawahara +6 more
2017PharmacoEconomics (Auckland)27 citations Open access
Semantic Scholar
Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer
N. Taira, H. Iwata, Y. Hasegawa, Takehiko Sakai +6 more
2014Breast Cancer Research and Treatment26 citations
Semantic Scholar
Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P
H. Murasawa, T. Sugiyama, Yuki Matsuoka, Takashi Okabe +8 more
2019Quality of Life Research19 citations
Semantic Scholar
Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole
H. Yagata, H. Ohtsu, Y. Komoike, S. Saji +5 more
2016Supportive Care in Cancer18 citations
Semantic Scholar
Japanese Population Norms for Preference-Based Measures: Eq-5d-3l, Eq-5d-5l, And Sf-6d.
T. Shiroiwa, T. Fukuda, S. Ikeda, A. Igarashi +3 more
2015Value in Health13 citations Open access
Semantic Scholar
Anemia affects the quality of life of Japanese cancer patients.
I. Wasada, H. Eguchi, M. Kurita, S. Kudo +12 more
2013The Tokai Journal of Experimental and Clinical Medicine13 citations
Semantic Scholar
Cost-effectiveness analysis of universal screening for biliary atresia in Japan.
E. Hoshino, K. Moriwaki, Kosuke Morimoto, K. Sakai +5 more
2022Jornal de Pediatria11 citations Open access
Semantic Scholar
Gradient Boosted Tree Approaches for Mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Onto 5-Level Version of EQ-5D Index for Patients With Cancer.
Y. Hagiwara, T. Shiroiwa, N. Taira, Takuya Kawahara +4 more
2022Value in Health11 citations Open access
Semantic Scholar
Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making
T. Shiroiwa, S. Saito, K. Shimozuma, S. Kodama +2 more
2016Applied Health Economics and Health Policy11 citations
Semantic Scholar
Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in Japan
S. Ohsumi, K. Shimozuma
2013Breast Cancer10 citations
Semantic Scholar
Cost-Effectiveness of Nab-Paclitaxel and Gemcitabine Versus Gemcitabine Monotherapy for Patients with Unresectable Metastatic Pancreatic Cancer in Japan.
Kosuke Morimoto, K. Moriwaki, Takako Kaneyasu, Hitomi Nakayama +1 more
2021Value in Health Regional Issues9 citations Open access
Semantic Scholar
Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems”
H. Murasawa, T. Sugiyama, Yuki Matsuoka, Takashi Okabe +10 more
2019Quality of Life Research9 citations Open access
Semantic Scholar
Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer
Takuya Kawahara, K. Shimozuma, T. Shiroiwa, Y. Hagiwara +6 more
2017Oncology9 citations Open access
Semantic Scholar
Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients’ Health Status in Greater Detail?
T. Shiroiwa, Y. Hagiwara, N. Taira, Takuya Kawahara +5 more
2021Medical decision making8 citations Open access
Semantic Scholar
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in Japan
Kosuke Morimoto, Kensuke Moriwaki, K. Shimozuma, Takeo Nakayama
2023Journal of gastroenterology7 citations
Semantic Scholar
Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups
E. Hoshino, Keiko Konomura, M. Obatake, K. Moriwaki +3 more
2022Pediatric surgery international (Print)7 citations Open access
Semantic Scholar
Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan
Xiu-Ting Mo, Kensuke Moriwaki, Kosuke Morimoto, K. Shimozuma
2022Clinical drug investigation7 citations
Semantic Scholar
Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan
K. Moriwaki, S. Uechi, T. Fujiwara, Y. Hagino +1 more
2021PharmacoEconomics - Open7 citations Open access
Semantic Scholar
Response Shift-Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation Modeling.
T. Murata, Y. Suzukamo, T. Shiroiwa, N. Taira +3 more
2020Value in Health7 citations Open access
Semantic Scholar
Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis
K. Oritani, K. Ohishi, S. Okamoto, K. Kirito +11 more
2018Current Medical Research and Opinion7 citations
Semantic Scholar
Realities in cost-effectiveness analyses: a study of castration-resistant prostate cancer patients using a medical claims database
S. Kunisawa, C. Tange, K. Shimozuma
2015SpringerPlus7 citations Open access
Semantic Scholar
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial
T. Shiroiwa, T. Fukuda, K. Shimozuma, M. Mouri +7 more
2017BMC Cancer6 citations Open access
Semantic Scholar
Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
Shoki Izumi, Y. Hagiwara, Y. Matsuyama, T. Shiroiwa +6 more
2023Health and Quality of Life Outcomes5 citations Open access
Semantic Scholar
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial
Y. Hagiwara, M. Sawaki, Y. Uemura, Takuya Kawahara +8 more
2021Breast Cancer Research and Treatment5 citations
Semantic Scholar
Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan.
C. Tange, S. Kunisawa, S. Maeda, K. Shimozuma
2015Value in Health5 citations Open access
Semantic Scholar
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
M. Oyama, T. Sugiyama, M. Nozawa, K. Fujimoto +7 more
2017Japanese Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Abstract P4-14-07: Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life two years after breast cancer surgery
N. Taira, K. Shimozuma, S. Ohsumi, K. Kuroi +3 more
20124 citations
Semantic Scholar
Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
Y. Takumoto, T. Shiroiwa, K. Shimozuma, H. Iwata +9 more
2022Clinical drug investigation3 citations Open access
Semantic Scholar
Reliability and validity of the Head and Neck Cancer Inventory (HNCI) in Japanese patients
Aya Yamashita, Kanako Ichikura, T. Sugimoto, S. Kishimoto +2 more
2015Palliative & Supportive Care3 citations
Semantic Scholar
Abstract P2-13-02: Patient-reported outcomes with trastuzumab monotherapy versus trastuzumab plus standard chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients (RESPECT): A randomized, open-label, phase 3 clinical trial
Kunihiko Kobayashi, N. Taira, M. Sawaki, N. Sagawa +8 more
2019Poster Session Abstracts2 citations
Semantic Scholar
Abstract P4-11-02: Subjective and objective assessment of efficacy of frozen gloves and socks to prevent nab-paclitaxel-induced peripheral neuropathy in patients with breast cancer
T. Yamashita, M. Hattori, T. Nakada, T. Hayashi +9 more
2019Poster Session Abstracts2 citations
Semantic Scholar
3．Practical Use of QOL/PRO for Health Technology Assessment in Japan
H. Murasawa, K. Shimozuma
2018Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku2 citations Open access
Semantic Scholar
Long-Term Eq-5d Score For Patients With Metastatic Breast Cancer; Comparison Of First-Line Oral S-1 And Taxane Therapies In The Randomized "Select" Trial.
T. Fukuda, T. Shiroiwa, K. Shimozuma, M. Mouri +7 more
2015Value in Health2 citations Open access
Semantic Scholar
Treatment Costs for Breast Cancer in Japan: Large Claim Database Analysis.
T. Shiroiwa, K. Shimozuma, T. Fukuda
2014Value in Health2 citations Open access
Semantic Scholar
Cost-effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan.
Tomomi Maeda, Kensuke Moriwaki, Kosuke Morimoto, Xiu-Ting Mo +3 more
2024Value in Health Regional Issues1 citations Open access
Semantic Scholar
Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have “Full-Health” by EQ-5D-5L
H. Murasawa, Yuki Matsuoka, N. Tanaka, Y. Takeda +3 more
20171 citations Open access
Semantic Scholar
Identification Of Important Criteria For Drug Reimbursement Decision-Making And Their Relative Importance
M. Funagoshi, Hideki Murasawa, K. Shimozuma
20171 citations Open access
Semantic Scholar
Abstract P5-15-09: National survey of chemotherapy-induced appearance issues in breast cancer patients
Takanori Watanabe, H. Yagata, M. Saito, H. Okada +7 more
20151 citations
Semantic Scholar
Abstract P3-10-01: Randomized phase III trial of taxanes versus S-1 as first-line chemotherapy for metastatic breast cancer (SELECT BC: CSPOR- MBC01)
Takanori Watanabe, K. Shimozuma, K. Imi, H. Doihara +11 more
20151 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Shiroiwa×20
Invite
T. Shiroiwa — researcher profile on SciRah
N. Taira×14
Invite
N. Taira — researcher profile on SciRah
T. Fukuda×13
Invite
T. Fukuda — researcher profile on SciRah
Y. Ohashi×13
Invite
Y. Ohashi — researcher profile on SciRah

×12

Invite

S. Noto — researcher profile on SciRah

Y. Hagiwara×11

Invite

Y. Hagiwara — researcher profile on SciRah

Invite

H. Mukai — researcher profile on SciRah

Takuya Kawahara×10

Invite

Takuya Kawahara — researcher profile on SciRah

Takanori Watanabe×8

Invite

Takanori Watanabe — researcher profile on SciRah

Keiko Konomura×6

Invite

Keiko Konomura — researcher profile on SciRah

Invite

S. Ohsumi — researcher profile on SciRah

Invite

Y. Uemura — researcher profile on SciRah